Back to search

National and Kapodistrian University of Athens

Πρωτολοίμωξη από HHV - 6 και πυρετικοί σπασμοί σε βρέφη και παιδιά

Abstract

dc:description

Human herpes virus 6 (HHV-6), first described in 1986, is a ubiquitous human herpes virus, acquired primarily in approximately 70% of infants by 24 months of age Two variants are classified on the basis of immunological and molecular biological analysis: type A (HHV-6A) and type B (HHV-6B). These are very closely related and display > 90% nucleotide identity, but pathogenesis and clinical manifestations differ substantially. Primary HHV-6B infection usually appears as exanthema subitum (ES) but neurological complications such as febrile seizures (FS) and encephalitis/encephalopathy can also occur. In contrast HHV-6A has predominantly been isolated from immunocompromised hosts, such as HIV/AIDS patients. In association with HIV infection, geographical variations exist between HHV-6A and HHV-6B. HHV-6A has been identified more frequently in a region in Africa, accounting for 44% of HHV-6 cases of non-specific illness among infants. After primary infection the virus remains latent not only in saliva, but also in CNS and may occasionally reactivate systematically under immunodeficient status. In immunocompetent hosts HHV-6 may reactivate during pregnancy or with HHV-7, measles or dengue infections. In recent years attention has focused on febrile seizures due to HHV-6 infection. Febrile seizures are an age depended condition occurring in children from 6 months to 5 years old. The current belief is that HHV-6 plays a causative role in FSs, based on the neurotropic properties of this virus and the similarity of the group in which febrile seizures and HHV-6 infection occur. In order to investigate the frequency and clinical characteristics of primary HHV-6 infection of hospitalized children with febrile seizures in our geographic region, we examined children (6 months to 5 years) without known neurological disease, for primary HHV-6 infection, by qualitative real-time PCR in acute phase plasma and anti-HHV-6 antibody titers in acute and convalescent (2-4 weeks later) serum by using indirect immunoflorescent assay (IFA). From November 2002 until December 2005, ninety-eight consecutive children aged 6 months to 5 years that were hospitalized in a tertiary Children’s hospital, for febrile seizures without known neurological disease were evaluated and examined for primary HHV-6 infection. Sixty-five of these children returned 2-4 weeks later for collection of convalescent-phase specimens. A standard questionnaire was given to the parents and they were informed about the purposes of the study. The history and clinical findings were recorded on a standard form as well as the diagnosis made at discharge. For the purpose of the study, the case definition of febrile seizures was a convulsive seizure in infants and children in association with fever, but without evidence of any definitive causative disease, such as CNS infection, metabolic abnormality or intoxication. Thus, both simple and complicated seizures were included. None of the patients had a history of febrile seizures. In addition to routine laboratory data (complete blood cell count, urinalysis, electrolyte determinations, cultures), blood samples were also collected and tested by qualitative real-time PCR in acute phase plasma and anti-HHV-6 antibody titers in acute and convalescent (2-4 weeks later) serum by using indirect immunoflorescent assay (IFA), from patients who agreed to be enrolled in the study. Whenever lumbar puncture was performed, CSF was also collected. HHV-6 DNA was extracted from blood samples using the commercially available High Pure Nucleic Acid kit (Roche) according to manufacture’s instructions. Real time PCR in blood sera was done by using the Light Cycler System 2. 0 as described elsewhere and the antibody titers to ΗHV-6 were measured by indirect immunofluorescence assay using the commercially available Biognost antibody Assay (Bios Gmbh, Mϋnchen, info@ bios-world. com). Eighty-five children hospitalized for elective surgery during the same time. period at the same hospital served as controls. A total of 65 children with febrile seizures were enrolled in the study, 36 were boys and 29 girls, mean age 21.35 months. Fifty-five patients had experienced febrile seizures for the first time and 10 had experienced a second episode. Primary HHV-6 infection was verified in 13 (13/65 = 20%) children. Mean age of these HHV-6 patients was 18.54 months. Ten of them had a positive for HHV-6 DNA by real time PCR in serum, while the remaining three were diagnosed as having HHV-6 primary infection by serology. HHV-6 DNA was not detected in three available CSF samples. Eight strains HHV-6 were identified by PCR as type B and two as type A. None of the controls had primary HHV-6 infection while 49.4% had IgG anti-HHV-6 antibodies. All children with primary HHV-6 infection had febrile seizures for the first time (13/55 = 23.6%). Six out of 13 (46.1%) HHV-6 positive children had typical roseola one of which was complicated with acute otitis media, 6 presented with respiratory or gastrointestinal infection, and one (7.2%) had no other symptoms than fever and seizures. Three of 13 children with primary HHV-6 infection and 8 of 52 children without, had complicated seizures (P, not significant). In the present study, it was observed that the two main clinical characteristics of children with primary HHV-6 infection were exanthema subitum and FSs. The majority of the HHV-6 infections were caused by type B viruses as expected, and only two infections were caused by HHV-6 type A viruses. The association between HHV-6 and FSs has been reported previously by others. Although in the present report a cause and effect relationship between HHV-6 and FS could not be established, all children with primary HHV-6 infection experienced their first episode of FSs. Moreover, in 24% (13/55) of children with a first episode of FSs the seizures were attributed to primary HHV-6 infection. On the contrary, the second episode of FSs was not associated with primary HHV-6 infection as has been noted by others [9]. Several studies have examined the role of primary HHV-6 infection in FSs. Among children with first episode of FSs primary HHV-6 was considered the cause of seizure in 26.2 to 42.8% of children, a percentage similar to that found in our study. On the other hand, 8 to 20% of children with primary HHV-6 infection had as a protean manifestation FSs. In contrast to those studies, all of our children (13/13) with primary HHV-6 infection experienced febrile seizures. This difference between our study and previous reports could be attributable to the different methodology, study design, and heterogeneity of the study populations. Moreover, virus strains isolated from diverse geographic location may have different biological properties. Notably, the majority of infections in the present study were caused by type B virus which is more frequently associated with febrile seizures. Although primary HHV-6 infection is found with high frequency among children with febrile seizures, whether a causal association truly exists remains to be proven. A case-control study of 35 children with FSs and 33 controls, did not show an association between HHV-6 and febrile seizures Nevertheless, an increasing number of studies support their association. Thus, in the medical literature it is considered that primary HHV-6 infection is an important factor in the pathogenesis of febrile seizures. Further research is needed to determine whether this association is causal. Table 1. Comparison of characteristics between patients with primary HHV- 6 infection and the non HHV-6 infection group. Febrile seizures Primary HHV-6 infection (n=13) Other infection* (n=52) p-values** Mean age (months) 18,54 24,16 0,37 Gender (male/female) 8/5 28/24 Febrile seizures First episode 13 42 0,61 Second episode 0 10 0,08 Complicated 3 8 0,58 Exanthem subitum 6 - 0,00 Laboratory Findings DNA for HHV-6 Plasma 10 - CSF 0/3 0,00 Serology IgM 5 - 1,00 IgG 8 37 1,00 IgM and 4-fold increase of IgG 11 - 1,00 * Other infection: 2 children with urinary tract infections (E. coli), 5 with otitis media, 1 with encephalitis, 3 with gastroenteritis (1 Campylobacter, 1 Salmonella), 3 with URI and 1 with pneumococcal bacteremia and the remaining 37 had other than HHV6 viral infections. ** Comparison between HHV-6 and non-HHV-6 group. In conclusion, our findings indicate that primary HHV-6 infection is frequently associated with febrile seizures in young children in our geographic region, and should be taken into consideration, especially in patients experiencing their first episode. The fact that 20% of the children seen in the emergency department with febrile seizures experience primary HHV-6 infection, supports the inclusion of HHV-6 detection in routine laboratory tests. Primary HHV-6 infection is not a risk for recurrent FSs.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Laina, Ioanna
  • Λαϊνά, Ιωάννα

Subjects

dc:subject × 11

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/23675

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Laina, Ioanna; Λαϊνά, Ιωάννα. Πρωτολοίμωξη από HHV - 6 και πυρετικοί σπασμοί σε βρέφη και παιδιά. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/23675